Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Watchlist Manager
Jiangsu Hengrui Pharmaceuticals Co Ltd Logo
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Watchlist
Price: 48.45 CNY -1.82% Market Closed
Market Cap: 307.6B CNY
Have any thoughts about
Jiangsu Hengrui Pharmaceuticals Co Ltd?
Write Note

Jiangsu Hengrui Pharmaceuticals Co Ltd
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiangsu Hengrui Pharmaceuticals Co Ltd
Non-Reccuring Items Peer Comparison

Comparables:
600196
H
3692
600436
000538
S
688506

Competitive Non-Reccuring Items Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Non-Reccuring Items
ÂĄ2.6m
CAGR 3-Years
-16%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Non-Reccuring Items
ÂĄ5.5m
CAGR 3-Years
-8%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Non-Reccuring Items
ÂĄ12.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Non-Reccuring Items
ÂĄ3.6m
CAGR 3-Years
-56%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Non-Reccuring Items
ÂĄ3.7m
CAGR 3-Years
N/A
CAGR 5-Years
-21%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Non-Reccuring Items
ÂĄ146.4k
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Non-Reccuring Items?
Non-Reccuring Items
2.6m CNY

Based on the financial report for Jun 30, 2024, Jiangsu Hengrui Pharmaceuticals Co Ltd's Non-Reccuring Items amounts to 2.6m CNY.

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 5Y
3%

Over the last year, the Non-Reccuring Items growth was -70%. The average annual Non-Reccuring Items growth rates for Jiangsu Hengrui Pharmaceuticals Co Ltd have been -16% over the past three years , 3% over the past five years .

Back to Top